Mithrl builds a scientific decision engine for biopharma and research teams. Its biomedical world model combines validated biological knowledge with each organization’s data, then uses AI agents and workflows to help scientists analyze experiments, assess hypotheses and accelerate drug-discovery decisions; the company is preparing its next-generation platform for broader deployment.
Headline
Activity from announced rounds
Headline is a global venture firm with local teams in the US, Europe, Latin America and Asia, combining regional investing with cross-border company-building relationships.
The firm’s offices include San Francisco, Berlin, Paris, London, São Paulo, Taipei and Tokyo. Its network supports introductions to customers, advisers and commercial partners beyond a company’s home market.
Headline has also helped coordinate transatlantic acquisitions between portfolio companies and supported public listings in multiple regions. Its model is useful to evaluate when international expansion, partnerships or an eventual cross-border transaction form part of a company’s plans.
Sources
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $266.5M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in this selectionProvides an AI-powered technology and marketing platform for local businesses
Combines humanoid robots and remote operators for warehouse and manufacturing labor